Global Soft Gelatin Capsules (Softgels) Market Size By Type (Gelatin Type, Non-animal Type), By Application (Pharmaceutical, Health Supplements), By Region, And Segment Forecasts, 2023 to 2032

The Global Soft Gelatin Capsules (Softgels) Market was valued at USD 8.4 billion in 2023 and is projected to reach USD 14.7 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. This growth is driven by increasing consumer preference for easily digestible and bioavailable dosage forms, the expanding nutraceutical and pharmaceutical industries, and advancements in capsule manufacturing technologies. Softgels are widely used to deliver both nutritional supplements and prescription medications due to their aesthetic appeal, taste-masking ability, and improved absorption characteristics.

Drivers:

1. Rising Demand for Nutraceuticals and Dietary Supplements:

The global health and wellness trend has significantly boosted the demand for vitamins, minerals, and herbal extracts, many of which are formulated as softgels due to their ease of swallowing and enhanced bioavailability.

2. Growth in the Geriatric Population:

With aging populations worldwide, there is an increased need for dosage forms that are easier to ingest and offer faster onset of action—both strengths of softgel capsules.

3. Technological Advancements in Encapsulation:

Innovations such as plant-based and non-gelatin alternatives, as well as improvements in encapsulation of complex ingredients (e.g., oils and fat-soluble vitamins), are supporting market expansion.

Restraints:

1. High Manufacturing Costs:

The production of softgels involves specialized machinery, temperature-controlled environments, and precise formulation, which increases operational costs compared to traditional tablets or hard capsules.

2. Stability Issues with Some Formulations:

Certain ingredients, particularly aqueous-based solutions, pose stability challenges when encapsulated in softgel formats, limiting their application scope.

Opportunity:

1. Surge in Demand for Plant-Based and Vegan Softgels:

Consumer shift toward vegetarian and vegan lifestyles has created an opportunity for manufacturers to develop gelatin-free softgel capsules using plant-derived materials like tapioca and starch blends.

2. Expansion in Emerging Economies:

Rising healthcare awareness, growing disposable incomes, and increased access to over-the-counter supplements in emerging markets such as India, China, and Brazil offer significant growth potential.

Market by System Type Insights:

By system type, the Gelatin-based Softgels segment accounted for the largest share in 2023, owing to its widespread use in pharmaceutical and nutraceutical applications due to its proven safety, cost-effectiveness, and flexibility in encapsulating lipophilic drugs.

However, the Non-gelatin Softgels segment is expected to witness the fastest growth during the forecast period, fueled by increasing demand for plant-based and allergen-free alternatives.

Market by End-use Insights:

Based on end-use, the Nutraceutical segment held the largest market share in 2023, driven by increasing consumer focus on preventive healthcare and dietary supplementation. Vitamins, omega-3 fatty acids, and herbal extracts are commonly formulated as softgels.

The Pharmaceutical segment is also expected to grow significantly, supported by the demand for high-bioavailability drug delivery systems for both prescription and OTC medications.

Market by Regional Insights:

Geographically, North America led the global softgel capsules market in 2023 due to the presence of major market players, a mature supplement market, and high consumer awareness.

Asia-Pacific is projected to grow at the fastest rate, supported by rising health awareness, expanding middle-class population, and increased investment in pharmaceutical manufacturing capabilities across countries like China and India.

Competitive Scenario:

Key players in the global soft gelatin capsules market include Catalent Inc., Aenova Group, Sirio Pharma Co. Ltd., EuroCaps Ltd., Captek Softgel International Inc., Thermo Fisher Scientific Inc., BASF SE, Lonza Group, Nature’s Bounty, and Soft Gel Technologies Inc. These companies are focusing on expanding their production capabilities, investing in plant-based capsule technologies, and strategic acquisitions to enhance their market presence.

Scope of Work – Global Soft Gelatin Capsules (Softgels) Market

Key Market Developments:

2023: Catalent Inc. launched a new line of plant-based softgel capsules targeting vegan consumers, with enhanced stability for botanical extracts.

2024: Lonza expanded its manufacturing facility in the U.S. to support increased demand for pharmaceutical-grade softgel production.

2025: BASF SE collaborated with a leading nutraceutical brand to co-develop lipid-based softgel formulations aimed at improving nutrient absorption.

FAQs:

1. What is the current market size of the Global Soft Gelatin Capsules (Softgels) Market?

The market size was valued at USD 8.4 billion in 2023.

2. What is the major growth driver of the Global Soft Gelatin Capsules (Softgels) Market?

The major driver is the growing demand for easy-to-consume and bioavailable dosage forms, especially in the nutraceutical sector.

3. Which is the largest region during the forecast period in the Global Soft Gelatin Capsules (Softgels) Market?

North America holds the largest market share due to its well-developed healthcare infrastructure and strong demand for supplements.

4. Which segment accounted for the largest market share in Global Soft Gelatin Capsules (Softgels) Market?

The Gelatin-based Softgels segment held the largest share by system type, while the Nutraceutical segment dominated by end-use.

5. Who are the key market players in the Global Soft Gelatin Capsules (Softgels) Market?

Key players include Catalent Inc., Lonza Group, BASF SE, Aenova Group, and Sirio Pharma Co. Ltd.